Natalie Miller

Quality Control Lab Coordinator at Elite Pharmaceuticals, Inc.

Natalie Miller serves as the Quality Control Lab Coordinator at Elite Pharmaceuticals, Inc. since April 2023. Prior experience includes working as a Personal Trainer at Crunch Fitness, where responsibilities involved guiding clients in fitness goals and sales of personal training packages. Natalie also held the role of Adult Fitness Professional at Parisi Speed School, developing daily workouts for group exercise classes. Additional experience includes training athletes and general fitness clients at Peac Performance, conducting health research as a Research Intern for the National Consortium for Building Healthy Academic Communities at Ohio State University, and early roles in customer service at White Beeches Golf & Country Club and as a Summer Camp Counselor. Natalie holds a Bachelor of Science in Kinesiology and Exercise Science from The College of New Jersey.

Location

New York, United States

Links

Previous companies


Org chart


Teams


Offices


Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals (“ECR”), a wholly owned subsidiary of Hi-Tech Pharmacal (“Hi-Tech”). Elite’s lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.